Recent advances in cell based therapies for lung diseases and critical illnesses offer
significant promise. Despite encouraging preclinical results, the translation of efficacy to the …

Acute respiratory distress syndrome (ARDS) causes respiratory failure, which is associated
with severe inflammation and lung damage and has a high mortality and for which there is …

In spite of decades of research, the acute respiratory distress syndrome (ARDS) continues to
have an unacceptably high mortality and morbidity. Mesenchymal stromal cells (MSCs) …

Mesenchymal stem/stromal cells (MSCs) have become the focus of intense research effort
over the past 10 years, in an effort to harness their regenerative and immune-modulating …

Introduction: Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising
therapeutic intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and …

There is considerable interest in the potential for cell-based therapies, particularly
mesenchymal stromal cells (MSCs) and their products, as a therapy for acute respiratory …

Recent clinical trials of mesenchymal stromal cell (MSC) therapy for various inflammatory
conditions have highlighted the significant benefit to patients who respond to MSC …

Abstract Purpose of Review Mesenchymal stromal cell (MSC)–based therapies provide a
platform for new therapeutic strategies in lung diseases. This review provides an overview of …

During acute or chronic lung injury, inappropriate immune response and/or aberrant repair
process causes irreversible damage in lung tissue and most usually results in the …

Respiratory diseases, such as chronic obstructive pulmonary disease and pulmonary
fibrosis, result in severely impaired quality of life and impose significant burdens on …